Response to "Fragility of Observed Associations in Selection of Empirical Antifungal Therapy for Critically Ill Non-Neutropenic Patients” [Response to Letter]
Infection and Drug Resistance · 2026-10 · Volume 19 · 1-3
DOI: 10.2147/idr.s639697 ↗Kurz gefasst
Leserbrief in der Zeitschrift Infection and Drug Resistance, 2026-10. Verfasst von Shahad A Albakri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Care Department, King Fahad Hospital, Ministry of Health, Madinah, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Pharmaceutical Care Department, King Fahad Hospital, Ministry of Health, Madinah, Saudi Arabia.
- Pharmaceutical Care Department, King Salman bin Abdulaziz Medical City, Madinah Health Cluster, Madinah, Saudi Arabia.
- Department of Pharmacy Practice, College of Pharmacy, Taibah University, Madinah, 41477, Saudi Arabia.
ORCID-Profile: Fahad Alzahrani
Zitieren
APA
Albakri, S. A., Aljabri, A. K., Alharbi, E. A., Alammash, B. B., Alabdali, S. A., Alahmadi, M. F., Almutairi, N. T., Alharbi, H. S., Alzahrani, F., & Alnezary, F. S. (2026). Response to "Fragility of Observed Associations in Selection of Empirical Antifungal Therapy for Critically Ill Non-Neutropenic Patients” [Response to Letter]. Infection and Drug Resistance, Volume 19, 1-3. https://doi.org/10.2147/idr.s639697
Vancouver
Albakri SA, Aljabri AK, Alharbi EA, Alammash BB, Alabdali SA, Alahmadi MF, et al. Response to "Fragility of Observed Associations in Selection of Empirical Antifungal Therapy for Critically Ill Non-Neutropenic Patients” [Response to Letter]. Infection and Drug Resistance. 2026;Volume 19:1-3. doi:10.2147/idr.s639697
BibTeX
@article{Albakri2026,
author = {Albakri, Shahad A and Aljabri, Ahmad K and Alharbi, Emad A and Alammash, Buthainah B and Alabdali, Salman A and Alahmadi, Maha F and Almutairi, Nawaf T and Alharbi, Hindi S and Alzahrani, Fahad and Alnezary, Faris S},
title = {Response to "Fragility of Observed Associations in Selection of Empirical Antifungal Therapy for Critically Ill Non-Neutropenic Patients” [Response to Letter]},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--3},
doi = {10.2147/idr.s639697}
}
EUVIMED